What Trans Mountain’s toll settlement changes for shippers

Pipeline developments are often described through a single capacity number. The Trans Mountain tolls settlement needs a more careful reading because its immediate subject is the commercial framework: how service, tolls and contracting are organized.

The CER’s September 28 announcement says the Commission approved the settlement, found the tolls just and reasonable, and cancelled the RH-002-2023 proceeding. The decision also permits Trans Mountain to contract up to 90% of pipeline capacity to shippers, compared with the previously approved 80% allocation. The Commission says other shippers can retain meaningful access to available capacity.

Four measures that should not be collapsed into one

Physical capacity describes a system’s ability to move product under a defined set of conditions. A contracting allocation describes how much capacity may be committed through a commercial arrangement. Booked service concerns the commitments actually made. Throughput records what the system moved during an observed period.

A change to one measure does not automatically establish a change to all four. The increase from 80% to 90% is a ten-percentage-point change in the permitted contracting allocation. It is not, by itself, a ten-per-cent construction expansion.

Likewise, permission to contract a larger share does not tell a reader how much has already been contracted, which parties hold those commitments, or how much product will flow next month. Those questions need their own records.

Why a toll framework matters

A transport option is valuable to a shipper only in relation to the full commercial route. The relevant calculation includes the selling price at the destination, transport charges and the terms of service. A headline benchmark price at a distant market cannot settle that calculation.

For example, an analyst comparing two destinations needs a consistent product specification and delivery basis. One price may already reflect a different point in the logistics chain. Comparing the displayed numbers without identifying that boundary can produce a false margin estimate.

The settlement therefore belongs in a commercial research file alongside tariff details and realized-price disclosures. It cannot substitute for either. It provides a change in the framework within which shipping economics are assessed.

Access and utilization need separate evidence

The public-interest question is broader than whether a pipeline exists. It includes how access is allocated, how competing requests are treated and how the system performs in practice.

The CER’s Pipeline Profiles provide a starting point for researching use, safety, tolls and financial information. An observed throughput series can help test whether additional market access is being used. It still cannot reveal every private shipping arrangement.

A reader should also keep the time periods straight. A decision announced in September and a throughput record for an earlier month describe different moments. The earlier record cannot establish the decision’s later effect. A before-and-after study needs enough subsequent observations to distinguish a persistent change from normal variation.

What this means for the Alberta market discussion

A producer-facing question is whether the framework changes its available commercial choices or transport cost. A national export question is whether destination mix shifts over time. A pipeline performance question is whether observed utilization changes. These can be related, but they are not interchangeable.

Evidence of higher overseas shipments would support a statement about destinations. Evidence of an issuer’s improved realized price would support a statement about that company’s sales. Establishing a causal connection between the two requires more than their timing.

The useful next steps are to read the approved decision and applicable tariff, follow contracting disclosures where public, and compare later throughput and export records on a consistent basis. The settlement is an established regulatory development; its full commercial effects remain a question to measure.